{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:36:04Z","timestamp":1770824164576,"version":"3.50.1"},"reference-count":67,"publisher":"Institute of Electrical and Electronics Engineers (IEEE)","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/ieeexplore.ieee.org\/Xplorehelp\/downloads\/license-information\/IEEE.html"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IEEE Trans. Med. Imaging"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1109\/tmi.2009.2012901","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T20:31:01Z","timestamp":1232483461000},"page":"916-925","source":"Crossref","is-referenced-by-count":91,"title":["Automated Quantitative Assessment of HER-2\/neu Immunohistochemical Expression in Breast Cancer"],"prefix":"10.1109","volume":"28","author":[{"given":"H.","family":"Masmoudi","sequence":"first","affiliation":[]},{"given":"S.M.","family":"Hewitt","sequence":"additional","affiliation":[]},{"given":"N.","family":"Petrick","sequence":"additional","affiliation":[]},{"given":"K.J.","family":"Myers","sequence":"additional","affiliation":[]},{"given":"M.A.","family":"Gavrielides","sequence":"additional","affiliation":[]}],"member":"263","reference":[{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200109000-00013"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1309\/6ANB-QXCF-EHKC-7UC7"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1075-122X.2005.00125.x"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/path.1354"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.4091"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.5.1215"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/path.1354"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900501)63:9<1761::AID-CNCR2820630918>3.0.CO;2-3"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.10.801"},{"key":"ref34","first-page":"19a","article-title":"inter-observer agreement in assessing c-erbb-2 status in breast cancer: immunohistochemistry and fish","volume":"190","author":"going","year":"2000","journal-title":"J Pathol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1109\/34.765658"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0636"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.01.002"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.99.178"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.061011"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2282011860"},{"key":"ref27","article-title":"the herceptin adjuvant (hera) trial study team: trastuzumab following adjuvant chemotherapy in her2-positive early stage breast cancer (hera trial): disease-free and overall survival after 2 year follow-up","year":"2006","journal-title":"J Clin Oncol 24"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880440"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.1999.17.7.1974","article-title":"comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of her-2\/neu in breast cancer","volume":"17","author":"jacobs","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2775"},{"key":"ref67","volume":"1981","author":"fleiss","year":"1981","journal-title":"Statistical Methods for Rates and Proportions"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg287"},{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi326"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1200\/JCO.1992.10.7.1044","article-title":"prognostic significance of her-2 oncoprotein expression in breast cancer: a 30-year follow-up","volume":"10","author":"toikkanen","year":"1992","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071167"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1990.8.1.103","article-title":"pathologic findings from the national surgical adjuvant breast and bowel project: prognostic significance of erbb-2 protein overexpression in primary breast cancer","volume":"8","author":"paik","year":"1990","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053028"},{"key":"ref23","first-page":"5s","article-title":"phase iii randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (acth) with docetaxel, carboplatin and trastuzumab (tch) in her2 positive early breast cancer patients: bcirg 006 study","volume":"94","author":"slamon","year":"2005","journal-title":"Breast cancer Res Treatment"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052306"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052122"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/01.pai.0000150516.75567.13"},{"key":"ref51","author":"wyszecki","year":"1982","journal-title":"Color Science Concepts and Methods Quantitative Data and Formulae"},{"key":"ref59","author":"soille","year":"2003","journal-title":"Morphological Image Analysis Principles and Applications"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1109\/ICPR.2002.1044864"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1109\/TIP.2005.852806"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2007.03.001"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1109\/TIP.2002.800889"},{"key":"ref54","author":"glassner","year":"1995","journal-title":"Principles of Digital Image Synthesis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1109\/ACV.2002.1182194"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1109\/TPAMI.2005.17"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1562"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/bcr738"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2174\/1386207043328445"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-200402000-00010"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800525"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600126"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800002"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3465"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.01.016"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"ref19","first-page":"53s","article-title":"her-2\/neu (c-erb-b2) gene and protein in breast cancer","volume":"112","author":"ross","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe020152"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05483-6"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.4.2.169"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200105000-00006"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.3.5.573"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","article-title":"prognostic factors in breast cancer: college of americal pathologists consensus statement 1999","volume":"124","author":"fitzgibbons","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"ref49","first-page":"495","article-title":"automated cellular imaging system (acis)-assisted quantitation of immunohistochemical assay achieves high accuracy in comaprison with fluorescence in situ hybridization assay as the standard","volume":"116","author":"wang","year":"2001","journal-title":"Anatom Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi352"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/002215540004800216"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1309\/AJ84-50AK-1X1B-1Q4C"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5858\/2006-130-1026-IAQAOP","article-title":"immunohistochemistry and quantitative analysis of protein expression","volume":"130","author":"cregger","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2001.01162.x"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/nm791"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1586\/14789450.2.3.325"},{"key":"ref44","first-page":"1445","article-title":"quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of her2 expression are associated with poor outcome","volume":"63","author":"camp","year":"2003","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.11.852"}],"container-title":["IEEE Transactions on Medical Imaging"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx5\/42\/4982914\/04752752.pdf?arnumber=4752752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:43:52Z","timestamp":1633913032000},"score":1,"resource":{"primary":{"URL":"http:\/\/ieeexplore.ieee.org\/document\/4752752\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":67,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1109\/tmi.2009.2012901","relation":{},"ISSN":["0278-0062","1558-254X"],"issn-type":[{"value":"0278-0062","type":"print"},{"value":"1558-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}